Abstract Aim
Introduction

A delay in bolus insulin secretion is a characteristic of early-stage type 2 diabetic patients. Its improvement by any kind of treatment is important for recovery of physiologic insulin concentration, obtaining tight glycemic control, delaying the disease process, and preventing diabetic complications.
Although intensive insulin treatment resembles the physiologic insulin secretion pattern, preventing diabetic complications (1) (2) (3) (Fig. 1a) No significant changes in postprandial plasma glucose levels (1 to 3 hours after breakfast) were seen throughout the study period (Fig. 1b) (Fig. 1c) .
T a b l e 1 . Cl i n i c a l Ch a r a c t e r i s t i c s o f t h e P a t i e n t s i n t h i s S t u d y
Materials and Methods
Study design
This study was performed as a multi-centered trial in
The frequency of hypoglycemic episodes did not differ before and after administration of the glinide (9 before administration, 10 during and 8 after discontinuation). No episode of serious hypoglycemia, requiring assistance, occurred during the study period.
Discussion
Many reports have documented combination therapy regimens with insulin and oral hypoglycemic agents. YkiJarvinen (6) 
T a b l e 2 . T h e Va r i a b l e s Me a s u r e d i n t h i s S t u d y
T h e r e we r e No S i g n i f i c a n t C h a n g e s i n An y o f t h e s e Va r i a b l e s adding lunchtime administration of glinide to this regimen.
We showed a significant positive effect of glinide administration at lunchtime in combination with twice daily injections of premixed insulin. Although one might argue that the change in HbA1c levels of -0.2% after 12 weeks is a "tiny" difference, the difference in HbA1c levels between twice daily injections of premixed insulin and intensive insulin treatment over 26 weeks was also only 0.2% (7.0% vs 6.8%, respectively) in the PREFER study (10) 
